Literature DB >> 21267700

Acquired cystic disease-associated renal cell carcinoma with gain of chromosomes 3, 7, and 16, gain of chromosome X, and loss of chromosome Y.

Naoto Kuroda1, Tomoyuki Shiotsu, Ondrej Hes, Michal Michal, Taro Shuin, Gang-Hong Lee.   

Abstract

Acquired cystic disease (ACD)-associated renal cell carcinoma (RCC) has been recently described. To date, there are no reports on genetic findings of G-band karyotype of ACD-associated RCC. In this article, we report the first report of G-band karyotype of ACD-associated RCC. A 66-year-old Japanese man was found to have a left renal tumor during the follow-up of hemodialysis consequent to chronic renal failure. Left nephrectomy was performed. Histological examination of three tumors in the left kidney showed the cribriform or microcystic growth pattern of neoplastic cells with eosinophilic cytoplasm, and many oxalate crystals were observed. The G-band karyotype of ACD-associated RCC showed 49, X, +X, -Y, +3, +7, +16. These chromosomal abnormalities resemble those of sporadic papillary RCC that has been previously reported. Finally, we suggest that this tumor may show a close relationship between ACD-associated RCC and papillary RCC, but a large-scale study will be needed to clarify the relationship between ACD-associated RCC and papillary RCC.

Entities:  

Mesh:

Year:  2011        PMID: 21267700     DOI: 10.1007/s00795-009-0465-8

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.309


  18 in total

1.  Atypical epithelial proliferations in acquired renal cystic disease harbor cytogenetic aberrations.

Authors:  Wah Cheuk; Elena S F Lo; Amanda K C Chan; John K C Chan
Journal:  Hum Pathol       Date:  2002-07       Impact factor: 3.466

2.  Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia.

Authors:  Satish K Tickoo; Mariza N dePeralta-Venturina; Lara R Harik; Heath D Worcester; Mohamed E Salama; Andrew N Young; Holger Moch; Mahul B Amin
Journal:  Am J Surg Pathol       Date:  2006-02       Impact factor: 6.394

3.  Chromosomal abnormalities in renal cell neoplasms associated with acquired renal cystic disease. A series studied by comparative genomic hybridization and fluorescence in situ hybridization.

Authors:  J Gronwald; A S Baur; H Holtgreve-Grez; A Jauch; F Mosimann; P Jichlinski; J P Wauters; T Cremer; L Guillou
Journal:  J Pathol       Date:  1999-02       Impact factor: 7.996

4.  Clinicopathologic and interphase cytogenetic analysis of papillary (chromophilic) renal cell carcinoma.

Authors:  M M Kattar; D J Grignon; T Wallis; G P Haas; W A Sakr; J E Pontes; D W Visscher
Journal:  Mod Pathol       Date:  1997-11       Impact factor: 7.842

5.  Renal cell carcinoma of end-stage renal disease: an analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification.

Authors:  M D Hughson; S Bigler; K Dickman; G Kovacs
Journal:  Mod Pathol       Date:  1999-03       Impact factor: 7.842

6.  Atypical cysts, acquired renal cystic disease, and renal cell tumors in end stage dialysis kidneys.

Authors:  M D Hughson; G R Hennigar; J F McManus
Journal:  Lab Invest       Date:  1980-04       Impact factor: 5.662

7.  High incidence of papillary renal cell tumours in patients on chronic haemodialysis.

Authors:  I Ishikawa; G Kovacs
Journal:  Histopathology       Date:  1993-02       Impact factor: 5.087

8.  End-stage kidney disease: gains of chromosomes 7 and 17 and loss of Y chromosome in non-neoplastic tissue.

Authors:  Ondrej Hes; Radek Síma; Jana Nemcová; Milan Hora; Stela Bulimbasic; Dmitry V Kazakov; Tomás Urge; Tomás Reischig; Miroslav Dvorák; Michal Michal
Journal:  Virchows Arch       Date:  2008-09-16       Impact factor: 4.064

9.  S100A1: a powerful marker to differentiate chromophobe renal cell carcinoma from renal oncocytoma.

Authors:  G Li; A Barthelemy; G Feng; A Gentil-Perret; M Peoc'h; C Genin; J Tostain
Journal:  Histopathology       Date:  2007-04       Impact factor: 5.087

10.  Renal cell carcinoma with intratumoral calcium oxalate crystal deposition in patients with acquired cystic disease of the kidney.

Authors:  Nathalie C Rioux-Leclercq; Jonathan I Epstein
Journal:  Arch Pathol Lab Med       Date:  2003-02       Impact factor: 5.534

View more
  12 in total

1.  Genomic profiling of renal cell carcinoma in patients with end-stage renal disease.

Authors:  Toru Inoue; Keiko Matsuura; Taichiro Yoshimoto; Lam Tung Nguyen; Yoshiyuki Tsukamoto; Chisato Nakada; Naoki Hijiya; Takahiro Narimatsu; Takeo Nomura; Fuminori Sato; Yoji Nagashima; Kenji Kashima; Shingo Hatakeyama; Chikara Ohyama; Kazuyuki Numakura; Tomonori Habuchi; Masayuki Nakagawa; Masao Seto; Hiromitsu Mimata; Masatsugu Moriyama
Journal:  Cancer Sci       Date:  2012-01-20       Impact factor: 6.716

2.  Clinical and pathological outcomes of renal cell carcinoma (RCC) in native kidneys of patients with end-stage renal disease: a long-term comparative retrospective study with RCC diagnosed in the general population.

Authors:  Alberto Breda; Giuseppe Lucarelli; Giuseppe Luccarelli; Oscar Rodriguez-Faba; Luis Guirado; Carmen Facundo; Carlo Bettocchi; Loreto Gesualdo; Giuseppe Castellano; Giuseppe Grandaliano; Michele Battaglia; Juan Palou; Pasquale Ditonno; Humberto Villavicencio
Journal:  World J Urol       Date:  2014-02-07       Impact factor: 4.226

3.  Clear cell renal cell carcinoma: a comparative study of histological and chromosomal characteristics between primary tumors and their corresponding metastases.

Authors:  Julien Dagher; Solène-Florence Kammerer-Jacquet; Frédéric Dugay; Marion Beaumont; Alexandra Lespagnol; Laurence Cornevin; Grégory Verhoest; Karim Bensalah; Nathalie Rioux-Leclercq; Marc-Antoine Belaud-Rotureau
Journal:  Virchows Arch       Date:  2017-05-10       Impact factor: 4.064

Review 4.  Role of cytogenetic biomarkers in management of chronic kidney disease patients: A review.

Authors:  Zeba Khan; Manoj Pandey; Ravindra M Samartha
Journal:  Int J Health Sci (Qassim)       Date:  2016-10

5.  Acquired cystic disease-associated renal cell carcinoma: an immunohistochemical and fluorescence in situ hybridization study.

Authors:  Naoto Kuroda; Motoki Yamashita; Yoshiyuki Kakehi; Ondrej Hes; Michal Michal; Gang-Hong Lee
Journal:  Med Mol Morphol       Date:  2011-12-17       Impact factor: 2.309

6.  Polo-like kinase 1 is overexpressed in renal cancer and participates in the proliferation and invasion of renal cancer cells.

Authors:  Guojun Zhang; Zhe Zhang; Zhuogang Liu
Journal:  Tumour Biol       Date:  2013-03-14

7.  Acquired cystic disease-associated renal cell carcinoma: further characterization of the morphologic and immunopathologic features.

Authors:  Soomin Ahn; Ghee Young Kwon; Yong Mee Cho; Sun-Young Jun; Chan Choi; Hyun-Jung Kim; Yong Wook Park; Weon Seo Park; Jung Won Shim
Journal:  Med Mol Morphol       Date:  2013-03-08       Impact factor: 2.309

Review 8.  Molecular genetics and immunohistochemistry characterization of uncommon and recently described renal cell carcinomas.

Authors:  Qiu Rao; Qiu-Yuan Xia; Liang Cheng; Xiao-Jun Zhou
Journal:  Chin J Cancer Res       Date:  2016-02       Impact factor: 5.087

9.  New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.

Authors:  Kiril Trpkov; Ondrej Hes; Sean R Williamson; Anthony J Gill; Adebowale J Adeniran; Abbas Agaimy; Reza Alaghehbandan; Mahul B Amin; Pedram Argani; Ying-Bei Chen; Liang Cheng; Jonathan I Epstein; John C Cheville; Eva Comperat; Isabela Werneck da Cunha; Jennifer B Gordetsky; Sounak Gupta; Huiying He; Michelle S Hirsch; Peter A Humphrey; Payal Kapur; Fumiyoshi Kojima; Jose I Lopez; Fiona Maclean; Cristina Magi-Galluzzi; Jesse K McKenney; Rohit Mehra; Santosh Menon; George J Netto; Christopher G Przybycin; Priya Rao; Qiu Rao; Victor E Reuter; Rola M Saleeb; Rajal B Shah; Steven C Smith; Satish Tickoo; Maria S Tretiakova; Lawrence True; Virginie Verkarre; Sara E Wobker; Ming Zhou
Journal:  Mod Pathol       Date:  2021-03-04       Impact factor: 8.209

10.  Expression of a Y-located human proto-oncogene TSPY in a transgenic mouse model of prostate cancer.

Authors:  Tatsuo Kido; Stephanie Schubert; Shingo Hatakeyama; Chikara Ohyama; Jörg Schmidtke; Yun-Fai Chris Lau
Journal:  Cell Biosci       Date:  2014-02-17       Impact factor: 7.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.